Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
Authors:
- Lama M. ChahineLCLama M. Chahine
- Daniel WeintraubDWDaniel Weintraub
- Keith A. HawkinsKHKeith A. Hawkins
- the PARS InvestigatorsTIthe PARS Investigators
- 21 August 2015
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 31 (1) , 86-94
Abstract
Objectives: The Parkinson Associated Risk Syndrome Study identified a cohort of healthy adults with hyposmia and dopamine transporter binding reduction to characterize individuals at risk for Parkinson's disease (PD). We describe the cognitive profile of this cohort.Methods: Individuals older than 50 y without PD were recruited. Two hundred twenty‐five completed cognitive testing and were included in the final analysis. A neuropsychological test battery was administered and normative scores created for global cognition, memory, executive function/working memory, processing speed/attention, visuospatial abilities, and language domains. Other non‐motor symptoms (constipation, depression, anxiety, and rapid eye movement sleep behavior disorder) were assessed through questionnaires.Results: Individuals with both hyposmia and reduced dopamine transporter binding (n = 38) had lower mean scores for global cognition, executive function/working memory, and memory compared with all other participants (n = 187). In separate multivariate logistic regression models, lower global cognition (odds ratio, 1.97, P = 0.004), and specifically executive function/working memory (odds ratio, 1.84, P = 0.004) scores were associated with membership in the hyposmia with dopamine transporter reduction group. Combining hyposmia with relative impairment on specific cognitive domains increased the odds of dopamine transporter binding reduction compared with hyposmia alone, with the greatest increase in odds for hyposmia plus executive function/working memory relative impairment (68% increase in odds from 4.14 to 6.96).Conclusion: Changes in global cognitive abilities, and specifically executive function/working memory, are present in individuals at risk for PD. Combining non‐motor features, including cognition, improves prediction of dopamine transporter binding reduction. © 2015 International Parkinson and Movement Disorder SocietyKeywords
This publication has 34 references indexed in Scilit:
- Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s DiseasePLOS ONE, 2013
- In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s diseaseJournal of Neural Transmission, 2012
- Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's diseaseMovement Disorders, 2012
- Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome studyMovement Disorders, 2012
- Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective studyMovement Disorders, 2009
- Premotor Parkinson's disease: Clinical features, detection, and prospects for treatmentAnnals of Neurology, 2009
- A critical evaluation of the Braak staging scheme for Parkinson's diseaseAnnals of Neurology, 2008
- Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment StudySchizophrenia Research, 2008
- Olfactory Deficits in Patients With Mild Cognitive Impairment Predict Alzheimer’s Disease at Follow-UpAmerican Journal of Psychiatry, 2000
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991